L&G HEALTHCARE BREAKTHROUGHL&G HEALTHCARE BREAKTHROUGHL&G HEALTHCARE BREAKTHROUGH

L&G HEALTHCARE BREAKTHROUGH

No trades
See on Supercharts

Key stats

Assets under management (AUM)
‪63.69 M‬CHF
Fund flows (1Y)
‪−34.45 M‬CHF
Dividend yield (indicated)
Discount/Premium to NAV
−1.2%

About L&G HEALTHCARE BREAKTHROUGH

Issuer
Legal & General Group Plc
Brand
L&G
Expense ratio
0.49%
Inception date
Jun 17, 2019
Index tracked
ROBO Global Healthcare Technology and Innovation ETF
Management style
Passive
ISIN
IE00BK5BC677
The L&G Healthcare Breakthrough UCITS ETF (the ETF) aims to track the performance of the ROBO Global Healthcare Technology and Innovation Index TR (the Index).

Classification

Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns

1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund

As of June 12, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.85%
Health Technology78.85%
Health Services9.35%
Commercial Services5.81%
Technology Services3.65%
Electronic Technology1.25%
Finance0.93%
Bonds, Cash & Other0.15%
Cash0.15%
Stock breakdown by region
85%12%2%
North America85.03%
Europe12.96%
Asia2.02%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends

Dividend payout history

Assets under management (AUM)

Fund Flows